Signet Healthcare Partners Mergers and Acquisitions Summary

Growth Capital Firm Profile

In the last 3 years, Signet Healthcare Partners has invested in 2 companies.

Signet Healthcare Partners’ most common sectors for investment arelife science (85%) and medical products (16%) . The Firm’s most common investment types include growth capital (62%) and venture (31%). In total, Signet Healthcare Partners has invested in 5 US states and 6 different countries.

Join Mergr to view Signet Healthcare Partners’ full profile and discover more middle-market growth capital firm investors just like it.

M&A Summary

  • M&A Total Activity13
    • M&A Buy Activity13
  • Total Sectors Invested 2
  • Total Countries Invested 6
  • M&A Buy/Sell Connections 3
  • M&A Advisors 2

Signet Healthcare Partners

Carnegie Hall Tower 152 West 57th Street, 59th Fl,
New York, 10019
United States
(646) 840-4990
www.signethealthcarepartners.com
louise.hamilton@signethp.com

Signet Healthcare Partners is a growth capital firm focused on the healthcare sector. Specific areas of interest include speciality pharmaceuticals, pharmaceutical services, medical devices, and diagnostics. Signet will consider opportunities throughout North America and Europe and looks to commit $10 to $50 million per transaction. Signet Healthcare Partners was established in 1998 and is headquartered in New York City.


Investment Criteria

Sectors of Interest: Healthcare Services, Life Science, Medical Products

Target Transaction Types: Growth Capital, Venture

Geographic Preferences: East US, Midwest US, South US, West US, Canada, United Kingdom, Western Europe, Scandinavia, Central Asia/India

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size 10 50
Enterprise Value - -
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.8/yr) # 9 2 2 - - - 13
Sell (0.0/yr) # - - - - - - 0
  13

Most Recent M&A

Company Date Value Type
Laxai Life Sciences Pvt Ltd. 2022-10-24 - Growth Capital
Hyderabad, India · www.laxai.com
Juno Pharmaceuticals Corp. 2022-02-24 - Growth Capital
Mississauga, Ontario · www.junopharm.ca
Ascendia Pharmaceuticals 2021-04-08 - Growth Capital
North Brunswick, New Jersey · www.ascendiapharma.com
Algorithme Pharma, Inc. 2021-02-22 - Secondary Buyout
Laval, Quebec · www.altasciences.com
RK Pharma, Inc. 2019-08-05 - Growth Capital
Pearl River, New York · www.rkpharmainc.com
Goodwin Biotechnology, Inc. 2019-04-22 - Growth Capital
Plantation, Florida · www.gbibio.com
Smart Medical Systems Ltd. 2018-02-15 - Venture
Ra’anana, Israel · www.smartmedsys.com
Leading Pharma LLC 2017-12-28 - Growth Capital
Fairfield, New Jersey · www.leadingpharma.com
Pharmaceutics International, Inc. (Pii) 2016-09-06 - Growth Capital
Hunt Valley, Maryland · www.pharm-int.com
Bionpharma, Inc. 2015-12-15 - Growth Capital
Princeton, New Jersey · www.bionpharma.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Life Science 11 (85%) - 11 (85%) -
Medical Products 2 (15%) - 2 (15%) -
Total 13 - 13 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 7 (54%) - 7 (54%) -
  New Jersey 3 (23%) - 3 (23%) -
  New York 1 (8%) - 1 (8%) -
  Maryland 1 (8%) - 1 (8%) -
  Florida 1 (8%) - 1 (8%) -
  California 1 (8%) - 1 (8%) -
Canada 2 (15%) - 2 (15%) -
  Ontario 1 (8%) - 1 (8%) -
  Quebec 1 (8%) - 1 (8%) -
Germany 1 (8%) - 1 (8%) -
India 1 (8%) - 1 (8%) -
Denmark 1 (8%) - 1 (8%) -
Israel 1 (8%) - 1 (8%) -
Total 13 - 13 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Growth Capital 8 (62%) - 8 (62%) -
Venture 4 (31%) - 4 (31%) -
Secondary Buyout 1 (8%) - 1 (8%) -
Total 13 - 13 -

Top M&A Advisors

Legal Deals
Sheppard Mullin Richter & Hampton LLP
 4
Troutman Pepper Hamilton Sanders LLP
 1

M&A Connections

Deals
Acquired from
Investor(s)
8%
1 (8%)

Investor Summary

Investor Type

Growth Capital Firm

Size

Middle-Market

PE Assets

500M USD

Established

1998

Specialist/Generalist

Specialist

Leadership

James Gale

Founding Partner & Managing Director

Ashley Friedman

Managing Director

Nikhil Puri

Managing Director

Theron Odlaug

Operating Partner

 Subscribe to unlock this and 193,848
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 184K M&A Transactions
  • 189K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.5K M&A Advisors
    (Investment Banks and Law Firms)
  • 72K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal